EP Patent

EP2145896A2 — Recovery of a heat shock protein

Assigned to Alfa Biogene International BV · Expires 2010-01-20 · 16y expired

What this patent protects

The present invention relates to a plant heat shock protein showing chaperone activity in combination with a vertebrae cochaperone for use as a medicament.

USPTO Abstract

The present invention relates to a plant heat shock protein showing chaperone activity in combination with a vertebrae cochaperone for use as a medicament.

Drugs covered by this patent

arimoclomol-citrate (ARIMOCLOMOL CITRATE)

Patent Metadata

Patent number: EP2145896A2
Jurisdiction: EP
Classification: —
Expires: 2010-01-20
Drug substance claim: No
Drug product claim: No
Assignee: Alfa Biogene International BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.